Mini Review
Published on 22 Nov 2022
The potential impact of melanosomal pH and metabolism on melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.887770
- 4,501 views
- 3 citations
- Frontiers in Oncology
- Skin Cancer
- Articles
Type at least 3 characters
420 articles
Review
Published on 17 Nov 2022
Immune checkpoint inhibitors for unresectable or metastatic pleomorphic dermal sarcomas
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.975342
- 4,452 views
- 12 citations
Case Report
Published on 17 Nov 2022
Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.978996
- 2,777 views
- 5 citations
Original Research
Published on 14 Nov 2022
PCDH9 suppresses melanoma proliferation and cell migration
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.903554
- 3,437 views
- 4 citations
Original Research
Published on 07 Nov 2022
Development and validation of prognostic index based on immunogenic cell death-related genes with melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1011046
- 2,248 views
- 4 citations
Original Research
Published on 07 Nov 2022
Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1020058
- 9,368 views
- 11 citations
Original Research
Published on 02 Nov 2022
A population-based cohort study for presence of ulceration among cutaneous malignant melanoma subgroups of patients
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.929600
- 1,643 views
- 1 citation
Original Research
Published on 27 Oct 2022
Nomograms for predicting the prognosis of patients with penoscrotal extramammary Paget’s disease: A retrospective study in the SEER database and two medical centers
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.973579
- 1,964 views
- 1 citation
Original Research
Published on 20 Oct 2022
Methylation-driven gene DLL3 is a potential prognostic biomarker in ocular melanoma correlating with metastasis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.964902
- 2,885 views
- 4 citations
Original Research
Published on 17 Oct 2022
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1001150
- 8,206 views
- 40 citations
Mini Review
Published on 14 Oct 2022
Melanoma lymph node metastases – moving beyond quantity in clinical trial design and contemporary practice
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1021057
- 6,491 views
- 6 citations
Original Research
Published on 13 Oct 2022
Cutaneous verrucous carcinoma: A clinicopathological study of 21 cases with long-term clinical follow-up
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.953932
- 5,126 views
- 9 citations
Original Research
Published on 12 Oct 2022
A novel melanoma prognostic model based on the ferroptosis-related long non-coding RNA
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.929960
- 3,381 views
- 6 citations
Review
Published on 06 Oct 2022
Causes, consequences and clinical significance of aneuploidy across melanoma subtypes
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.988691
- 3,729 views
- 4 citations
Systematic Review
Published on 30 Sep 2022
The impact of merkel cell polyomavirus positivity on prognosis of merkel cell carcinoma: A systematic review and meta-analysis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.1020805
- 3,210 views
- 18 citations
Original Research
Published on 29 Sep 2022
Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.975643
- 4,390 views
- 7 citations